In honor of October's Liver Cancer Awareness month, we are offering a special promotional code for 25% registration for our Third Annual Primary Care Summit (Virtual). Register today and use the code PCPROMO25 at https://lnkd.in/gnZvCUxR American Association for the Study of Liver Diseases (AASLD), EASL the home of Hepatology, Global NASH Council, Global Liver Institute, Canadian Association for the Study of the Liver, Canadian Nurses Association, Canadian Family Physician, Canadian Association Of Ambulatory Care, Canadian Association of Hepatology Nurses, European Liver Patients' Association - ELPA, LPI LIVER PATIENTS INTERNATIONAL, American Diabetes Association, Paul Brennan, Christopher Kopka, Jeffrey V. Lazarus, Zobair Younossi, Livera Health, Mark Donnison, MBA, Philippe Garneau, Supriya Joshi, Hsiao-Ming Jung, Cheryl Dale RN(EC) MScN AF-AASLD, Pinnacle Clinical Research, Arizona Liver Health , Houston Liver Institute, Summit Clinical Research, Naim Alkhouri, MD, FAASLD, RACHAEL SOOD RN, MSN, APRN, NP-C, CDCES, Mazen Noureddin, MD, MHSc, Supriya Joshi, James Kim, Prof. Shira Zelber Sagi, Giada Sebastiani, Noah Ivers, Richard Ward, Stephanie Gysel
Fatty Liver Alliance
Non-profit Organizations
Awareness, Education, Research and Advocacy to support patients living with fatty liver disease and MASH.
About us
Our mission is to raise awareness about the risks, causes and complications of fatty liver disease and help those already diagnosed with non-alcoholic fatty liver disease (NAFLD/MASLD) and non-alcoholic steatohepatitis (NASH/MASH) by advocating for access to approved treatments and care.
- Website
-
http://www.fattyliver.ca
External link for Fatty Liver Alliance
- Industry
- Non-profit Organizations
- Company size
- 2-10 employees
- Headquarters
- Toronto, Ontario
- Type
- Nonprofit
- Founded
- 2021
Locations
-
Primary
Toronto, Ontario, CA
Updates
-
Here is a definite must read paper about MASLD and MASH, just out, and from the perspective of Radiologists. "MASLD: What We Have Learned and Where We Need to Go—A Call to Action". Congratulations to Claude Sirlin, Sedighe Hosseini Shabanan et al. for this wonderful paper highlighting so many factors we all need to consider, including the fact that “since 2010, 30 clinical practice guidelines and consensus statements on MASLD have been released. Of the 459 unique authors who have contributed to these important documents, only two have been radiologists based on the published affiliations and no radiology societies have participated.” “In this pictorial review, the authors present the latest insights into MASLD, covering its recent nomenclature change, spectrum of disease, epidemiology, morbidity, and mortality. The authors also discuss current qualitative and quantitative imaging methods for assessing and monitoring MASLD.” “Last, they propose six unsolved challenges in MASLD assessment, which they term the proliferation, reproducibility, reporting, needle-in-the-haystack, availability, and knowledge problems.” Link to this Radiographics paper: https://lnkd.in/gxSdyv-2
-
First time playing outdoor Pickleball. First time was indoors at EASL | The Home of Hepatology 2024. That’s 30 minutes more towards my 150 minutes this week! American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Prof. Shira Zelber Sagi, Jonathan G. Stine, MD MSc, FACP, Manal Abdelmalek, Naim Alkhouri, MD, FAASLD, Global Liver Institute
-
How wonderful is it when community members have a chance to see, to feel, to really understand what Fatty Liver Disease is? Thank you Madrigal Pharmaceuticals for lending us this model to share with the Vancouver community - they were fascinated by it. American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, Global Liver Institute, European Liver Patients' Association - ELPA, LPI LIVER PATIENTS INTERNATIONAL, Global NASH Council, Livera Health, Liver Scan Direct, Alnoor Ramji, Giada Sebastiani Link to video (first one on page) https://lnkd.in/giYx2qE5
Fatty Liver Alliance
fattyliver.ca
-
Join us for the Third Annual Primary Care MASLD/MASH Summit on Thursday, December 5, 2024—a dynamic virtual event focused on advancing knowledge and collaborative care for MASLD (Metabolic dysfunction-associated Steatotic Liver Disease) and MASH (Metabolic dysfunction-associated Steatohepatitis). Co-hosted by CanNASH and the Fatty Liver Alliance, this summit brings together healthcare professionals to discuss the latest approaches for treating and managing these liver conditions. Don’t miss our Case Study and Panel Discussion including James Kim on Real-World Applications and Collaborative Care. Learn from an interdisciplinary panel of experts, including perspectives from Primary Care, Nurse Practitioners, Hepatologists, Endocrinologists, Cardiologists, and Nutritionists. Dr. Kim will also highlight Canada’s guidelines on "T2DM and MASLD“. This session is designed to provide practical insights into how collaborative efforts can improve patient outcomes, equipping you with the tools and strategies to integrate MASLD/MASH care into your practice. Register now https://lnkd.in/gUYJsqGz to be part of this essential discussion and gain learning credits while enhancing your understanding of MASLD and MASH. Canadian Association for the Study of the Liver, Giada Sebastiani, Sahar Saeed, Supriya Joshi, The College of Family Physicians of Canada Diabetes Canada Global NASH Council Global Liver Institute European Liver Patients' Association - ELPA LPI LIVER PATIENTS INTERNATIONAL, Barcelona Institute for Global Health (ISGlobal), Mazen Noureddin, MD, MHSc, Naim Alkhouri, MD, FAASLD, Hsiao-Ming Jung, Cheryl Dale RN(EC) MScN AF-AASLD, Mark Donnison, MBA, Philippe Garneau, Jeff McIntyre, MCI, Prof. Shira Zelber Sagi, Christopher Kopka, Paul Brennan, Mia J Biondi, PhD, NP-PHC, Supriya Joshi
-
“Advocating for orchestrated international collaboration in MASLD prevention and management, particularly in low-income countries, is imperative. Urgent action is also necessary to formulate comprehensive strategies at both national and global levels to confront the challenge of MASLD.” This paper found “the assessment and stratification of CAC may be useful in predicting a high risk of CVD events in patients with MASLD,” Kang and colleagues concluded.” Original reference: Kang MK, Song J, Loomba R, et al. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification. Preprint. Res Sq. 2024;rs.3.rs-3979461. Published 2024 Mar 5. https://lnkd.in/gm6RMcs4 American Association for the Study of Liver Diseases (AASLD) EASL | The Home of Hepatology Global NASH Council Global Liver Institute European Liver Patients' Association - ELPA Canadian Association for the Study of the Liver American College of Cardiology Barcelona Institute for Global Health (ISGlobal)
Research Elucidates MASLD Association With Cardiovascular Disease
hcplive.com
-
We are looking forward to the upcoming MOSAiC Trialists think tank and our patient panel discussion with Henry Chang and Wayne Eskridge from Fatty Liver Foundation, with Jeff McIntyre from Global Liver Institute, with Margaret Padilla and Michael Betel from Fatty Liver Alliance. For those who will be attending, we look forward to seeing you there! Arun Sanyal, VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Faiez Zannad, Javed Butler, Veronica Miller, Zobair Younossi, Vlad Ratziu, Sven Francque, Alina M. Allen, Kimberly Martinez, Jennifer Berg, Pascaline Clerc-Brenner, PhD, Mark Hartman, Lars Johansson, Michelle Long, Rebecca Taub, Ramy (Massimo) Younes, MD, PhD, Yann Colardelle, Paul Brennan, Mark Levenson, Translational Medicine Academy (TMA), Pablo J Prado, Ph.D., Christopher Kopka
-
Loved our chat this morning with Naim Alkhouri, MD, FAASLD, from Arizona Liver Health hosted by Medscape Education where we discussed lifestyle management for patients who have MASH, as part of the Monster MASH Monday events. Here are 5 key take-aways from today's chat: 1. Individualized Lifestyle Changes: Both Dr. Alkhouri and Michael Betel emphasized that lifestyle changes, such as diet and exercise, need to be individualized. What works for one person may not work for another, and it is essential to modify behaviors based on each patient's circumstances. 2. Diet Plays a Major Role: Both speakers highlighted the importance of diet in managing MASH. Dr. Alkhouri reiterated that weight loss is 80% about diet and 20% about exercise, stressing the need to avoid junk food, sugary drinks, and processed foods while encouraging whole, minimally processed options. Michael also mentioned that tracking carbs and sugars is crucial. 3. Incorporating Physical Activity: Simple changes like taking the stairs, parking further away, and walking after meals can help improve overall activity levels. Walking, even briefly after meals, was found to lower glucose levels, and aiming for 10,000 steps a day is a great target. 4. Small, Sustainable Steps: Both speakers agreed that lifestyle changes should be realistic and sustainable. Instead of drastic measures, patients should focus on gradual modifications that they can stick with over time. This includes mindful eating and balancing occasional indulgences with healthier choices. 5. Supporting Patients in Change: Healthcare providers can motivate patients by personalizing their advice, understanding individual barriers, and recommending tools like digital apps or meal plans to support behavior change. Using motivational interviewing and providing practical, accessible resources can enhance long-term success. American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, Global NASH Council, Global Liver Institute, European Liver Patients' Association - ELPA, LPI LIVER PATIENTS INTERNATIONAL, The Forum for Collaborative Research: Liver Forum, Jörn M. Schattenberg, Manal Abdelmalek, Supriya Joshi, Meena Bansal, Jeffrey V. Lazarus Prof. Shira Zelber Sagi, RACHAEL SOOD RN, MSN, APRN, NP-C, CDCES, Pinnacle Clinical Research Summarized in collaboration with CHATGPT4o.
-
Join Naim Alkhouri, MD, FAASLD and Michael Betel tomorrow morning for a quick chat about lifestyle and MASLD/MASH. Grab a coffee and see you then. Live on Medscape Education’s LinkedIn, Facebook and YouTube pages.
-
October is liver cancer awareness month around the world, and it is a perfect time to share today's blog for some weekend reading. Why is early detection critical? What is the spectrum of disease from MASLD to MASH to HCC? Why is early case finding so important? Can early detection prevent liver cancer? Is it time to shift our thinking to cancer prevention? Check out our blog today where we share our thoughts on this life saving topic. American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Global NASH Council, The Forum for Collaborative Research: Liver Forum, Global Liver Institute, European Liver Patients' Association - ELPA, LPI LIVER PATIENTS INTERNATIONAL, Livera Health, Predictive Health Intelligence, Aegle Medical, Echosens, Nature Portfolio, Perspectum Ltd, E-Scopics, LiverScan Direct, KNS Canada Inc., American College of Radiology, American Diabetes Association, Canadian Association for the Study of the Liver, Aegle Medical, Michael P. McTighe, Brian E. Sanders, MBA
Liver Cancer: From MASLD to MASH to HCC
fattyliver.ca